lobbying_activities: 1296213

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1296213	48be7002-207e-4a0e-a8ce-68a264776bba	Q3	GREATER NEW YORK HOSPITAL ASSOCIATION	16830	GREATER NEW YORK HOSPITAL ASSOCIATION	2012	third_quarter	PHA	Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187); issues related to unique device identification.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office		210000	0	0	2012-10-10T09:52:07.243000-04:00